Clinical Trial Update: Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2) [NA]

View source ↗

Summary

Trial update for the EXACT2 study evaluating exercise to prevent anthracycline-induced cardiotoxicity in breast cancer patients; the trial is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Cancer, Breast, Cardiotoxicity | NA | Status: ACTIVE_NOT_RECRUITING